However, this is not favourable to the medicine/pharmaceutical industry, it certainly won't increase sales, profits and stock options.
"Experts estimate that a staggering 98,000 people die from preventable medical errors each year. More Americans die each month of preventable medical injuries than died in the terrorist attacks of Sept. 11, 2001.
In addition, a federal Centers for Disease Control and Prevention study concluded that 99,000 patients a year succumb to hospital-acquired infections. Almost all of those deaths, experts say, also are preventable.
These numbers are not absolutes. There is no definitive study — which is part of the problem — but all of the available research indicates that the death toll from preventable medical injuries approaches 200,000 per year in the United States.
Ten years ago, a highly publicized federal report called the death toll shocking and challenged the medical community to cut it in half — within five years.
Instead, federal analysts believe the rate of medical error is actually increasing.
A national investigation by Hearst Newspapers found that the medical community, the federal government and most states have overwhelmingly failed to take the effective steps outlined in the report a decade ago.
Hearst also found that in states like California that have put some regulations in place, hospitals often ignore the rules without penalty.
Consequently, over that period, as many as 2 million Americans have died needlessly of preventable medical mistakes."
Why were these problems never addressed? I will bold the relevant section.
Back in November 1999, the report titled “To Err Is Human” was issued with the highest of hopes. Its authors believed it promised the start of a revolution in patient safety.
The report certainly sparked awareness of the scale of the problem. But some of its authors say the revolution was doomed by a lack of political leadership and the health care lobby's vested interest in maintaining business as usual, especially secrecy surrounding dangerous medical errors.
In other words, the healthcare industry, through their lobbyists ensured a lack of political leadership to address the problem.
The swine flu however is highly profitable. I wonder did the lobbyists ensure the political leadership addressed the H1N1 issue head on
Here is a just a sampling of headlines telling readers the pharmaceutical companies are reaping the benefits.
Novartis sees faster growth, H1N1 boost in Q4
It is turning out to be a better year for big drugmakers like Novartis than initially feared, thanks to hefty price increases and windfall sales from swine fluCompanies reap the swine flu windfall
Healthcare companies are reaping the benefits of a global swine flu pandemic, brightening what might otherwise have been a dismal third quarter and bringing new focus on the market for vaccines. (the market for vaccines, something to be sold to you, like a car)While swine flu has killed about 4,000 worldwide in 191 countries and send thousands home sick to suffer alone with its symptoms, the H1N1 swine flu virus may prove very lucrative for drug maker GlaxoSmithKline Plc. (GSK).Glaxo’s Swine Flu Windfall
While swine flu has killed about 4,000 worldwide in 191 countries and send thousands home sick to suffer alone with its symptoms, the H1N1 swine flu virus may prove very lucrative for drug maker GlaxoSmithKline Plc. (GSK).